GLP-1(936) inhibits PKA activity by a G i/o -dependent mechanism The GCGR can activate both stimulatory (G s ) and inhibitory (G i/o ) GTP-binding proteins [33,34,35] and may therefore mediate the PTX-sensitive effects of GLP-1(936)
Since this is a new delivery platform of existing drugs rather than a new drug, the regulatory bodies in many jurisdictions typically have alternative, shorter approval pathways available to drug sponsors that do not require the standard Phase I-III clinical trials for a new drug application
Sublingual nausea tends to be milder than injection-related nausea because the medication absorbs more gradually
Phentermine is a sympathomimetic agent that increases heart rate and blood pressure through norepinephrine release
Search strategy A comprehensive evaluation of preclinical and clinical studies was conducted to explore the possible association between GLP-1RAs and PDAC
Funding The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article